OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
29
Results
Show all
Save search
Copy query
Show results for
Unknown
(29)
Publication Date
Release Date
2021
(9)
2025
(7)
2022
(6)
2024
(3)
2023
(2)
2019
(1)
2018
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088
|
biostudies-literature
Cite
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
Not available
S-EPMC8360544
|
biostudies-literature
Cite
Awareness and preparedness of healthcare workers against the first wave of the COVID-19 pandemic: A cross-sectional survey across 57 countries.
Not available
S-EPMC8694437
|
biostudies-literature
Cite
Management and Outcomes Following Surgery for Gastrointestinal Typhoid: An International, Prospective, Multicentre Cohort Study.
Not available
S-EPMC6132852
|
biostudies-literature
Cite
Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study).
Not available
S-EPMC9071082
|
biostudies-literature
Cite
Global variation in anastomosis and end colostomy formation following left-sided colorectal resection.
Not available
S-EPMC6921967
|
biostudies-literature
Cite
Global economic burden of unmet surgical need for appendicitis.
Not available
S-EPMC10364778
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets